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Ring Chromosome 20 syndrome is a rare chromosomal disorder characterized by refractory epilepsy,
with seizures in wakefulness and sleep, behavioral problems and mild to severe cognitive impairment.
Facial dysmorphism or other congenital malformations are rarely reported making it difﬁcult to diagnose
the syndrome based on clinical ﬁndings alone. Therefore, diagnosis requires cytogenetic testing. More
than 100 cases have been published since the initial report in 1972. In some patients, the ring (20) is
found in all cells analyzed and in these cases, the ring is almost always accompanied by deletions of
20pter and/or 20qter. However, in the majority of cases the ring is present in only a proportion of cells,
with two normal 20’s in the remaining cells (mosaicism), and in these cases, no deletions of chromosome
20 have been observed. Patients with supernumerary r(20) chromosomes have also been identiﬁed, but
these individuals do not generally have seizures and are not discussed in this review. Characterization by
ﬂuorescence in situ hybridization and array-based analysis has shed insight into the molecular compo-
sition and possible mechanisms of ring formation, in both the mosaic and non-mosaic patients. The age
of onset of seizures correlates with the percentage of cells with the ring in mosaic patients. While the
underlying etiology of the phenotype is still not understood, evidence is accumulating which suggests
the deletion of candidate genes on chromosome 20 is not responsible. Cytogenetic analysis, rather than
chromosomal microarray analysis is recommended for diagnosis of this syndrome, as the mosaic cases do
not have copy number alterations and are therefore not identiﬁed by array-based analysis.
 2012 Elsevier Masson SAS. All rights reserved.1. Introduction
Constitutional ring chromosomes have been identiﬁed for each
of the human chromosomes, and the overall frequency is estimated
at 1 in 30,000 to 60,000 births [1]. Rings result from rare intra-
chromosomal fusions although mechanism(s) underlying chro-
mosomal ring formation are not completely understood. These
fusion events are hypothesized to arise from either unstable telo-
meres, which directly fuse, or from chromosomal breaks that
resolve by fusion of the two chromosomal arms. The latter are often
accompanied by additional aberrations including terminal army and Laboratory Medicine,
ch Center, 3615 Civic Center
19104, USA. Tel.: þ215 590
. Spinner).
on SAS. All rights reserved.deletions, duplications and/or inversions [2e4]. The timing of the
fusion event determines how many cells are affected, and ring
formation can occur in either the germ line or somatic cells. Ring
formation in germ line cells results in patients who have the ring
chromosome present in every cell (non-mosaic) while post-zygotic
fusions affect only a subset of cells (mosaicism) [5e7]. Familial
transmission of ring chromosomes has been reported, however,
most cases are sporadic with no gender or ethnicity bias [5,6,8,9].
While this review focuses only on ring chromosome 20, there is
suggestion that there may be phenotypic overlap with ring other
chromosomes, resulting inwhat has been coined a ‘ring syndrome’.
This commonality across ring syndromes led to the hypothesis that
the ring itself, irrespective of the speciﬁc sequences involved, may
cause clinical abnormalities [10]. However, evidence is conﬂicting.
It has been hypothesized that the growth failure associated with
‘ring syndrome’ is related to haploinsufﬁciency due to speciﬁc
deletions within ring chromosomes, rather than the ring itself
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all rings have associated deletions, even if the phenotype compares
to the deletion-associated ring [8,16,17]. In addition, not all patients
with a ring chromosome have growth deﬁciency (including
patients with ring chromosome 20). Currently, based on variability
in phenotypes of different ring chromosomes, there is limited
support for the existence of a ring syndrome [8,17e21]. Work is
ongoing to determine how the presence of a ring chromosome
alters expression of genes on the ring and elsewhere in the
genome; comparison of this data for different rings will provide
information on similarities in genomic effects of different ring
chromosomes.
Ring chromosome 20was ﬁrst reported in 1972 in a patient with
epilepsy, intellectual disability and abnormal behavior [22]. Addi-
tional case reports of individuals presenting with epilepsy led to
the description of a ring chromosome 20 syndrome [23,24]. Since
then, nearly 100 patients in 70 reports on have been described,
most with intractable epilepsy, variable cognitive impairment
and/or behavioral problems [1,8,9,12,16,17,25e31]. In some of these
cases, development was normal until seizure onset, suggesting that
the syndrome be considered an epileptic encephalopathy. To date,
the pathogenic etiology underlying the seizure phenotype is still
unknown. Here we review the published cases, and detail both the
clinical phenotype and what is currently known about the under-
lying genetics.
2. Clinical phenotype
Ring chromosome 20 syndrome is characterized by medically
intractable focal epilepsy with seizure onset in childhood and an
electroencephalogram (EEG) demonstrating long epochs of bilat-
eral high amplitude slowactivity with intermixed frontal spikes [8].
Seizures are typically partial complex in nature with altered
consciousness including staring, automatisms, and focal motor
symptoms [8,13,25,32,33]. Patients may describe periods of intense
fear and sometimes prolonged, confusional states lasting for
minutes to hours (non-convulsive status epilepticus), which
appears to be a characteristic seizure type in r(20) patients [13].
Ictal visual hallucinations have also been described [8,32,33]. In
addition, subtle nocturnal seizures with behavioral changes such as
stretching, rubbing and turning have been observed which
resemble normal arousal behavior or mistaken for non-epileptic
events [25,32]. Video-EEG monitoring can be preformed to distin-
guish epileptic from non-epileptic events. Seizures are typically
difﬁcult to control with antiepileptic medications and patients are
subjected to epilepsy surgery workup and unnecessary investiga-
tions unless the diagnosis of r(20) has been made [8,13,25,33].
Unlike other chromosomal aberrations, dysmorphisms are
uncommon and most patients appear phenotypically normal
[17]. Normal development prior to seizures is common
[8,13,25,30,32,34,35]. After onset, varying degrees of intellectual
impairment and behavioral problems have been reported.
Seizure onset is typically between ages 1 and 24 years, with an
average of 7e9 years in mosaic patients and 2.5 years for patients
with the ring in all cells [17,32]. Earlier seizure onset is associated
with more severe intellectual impairment [36,37]. While the age
of onset and severity are variable, seizure semiology is consistent,
as described above.
A wide spectrum of EEG abnormalities is seen in r(20) patients.
Interictal EEG background may be normal to mildly slow or
demonstrate bursts of sharply contoured theta activity. Runs of
bi-frontal spike and wave activity have been reported as a distinct
pattern in r(20)syndrome (Fig. 1B) [8,13,36,38]. Ictal EEGs
point to frontal onset, prolonged runs of diffuse slowing with
frontal dominance intermixed with bi-frontal sharp wavedischarge are seen with non-convulsive status epilepticus (Fig. 1C)
[8,13,25,32,35]. Magnetoencephalography in one patient conﬁrmed
frontal lobe involvement [39]. The lack of dysmorphic abnormali-
ties and the fact that frontal lobe epilepsy in not speciﬁc to the r(20)
syndrome presents a challenge for the timely diagnosis of this rare
disorder.
2.1. Neuroimaging
A wide spectrum of structural and functional neuroimaging
studies have been performed in patients with r(20) syndrome.
Structural abnormalities are not seen in themajority of the patients,
although minor structural abnormalities have been occasionally
reported. A [18F] ﬂuoro-L-DOPA PET study in patients with r(20)
showed decreased uptake in the basal ganglia, emphasizing the
importance of subcortical structures in epileptic mechanisms [40].
A recent SPECTstudy supported the role of the dopaminergic system
in epilepsy in patients with r(20) syndrome [41].
2.2. Differential diagnosis
Both clinical and electroencephalographic ﬁndings in patients
with r(20) syndrome can be confused with other refractory
epilepsy syndromes. LennoxeGastaut syndrome (LGS), is charac-
terized by medically refractory mixed intractable seizures but the
tonic and atonic seizures (drop attacks) characteristic of LGS are
rarely seen in r(20) syndrome. Frontal lobe epilepsy of any etiology
has seizure phenomenology and EEG similarities with r(20)
syndrome. The nocturnal EEG pattern in r(20) may also have
features of Continuous Spike and Wave discharges in Slow Wave
Sleep (CSWS) [32].
2.3. Treatment and outcome
Management of children with r(20) is based on each child’s
symptoms. The percentage of cells with the ring(20) in mosaic
patients appears to be inversely correlated with response to anti-
epileptic drugs [17,42]. From the review of published literature, no
single drug is most effective, and medical intractability frequently
leads to multiple antiepileptic drug exposure. Some authors report
more favorable outcome with a combination of valproate and
lamotrigine [8,9,32].
Epilepsy in r(20) syndrome is not amenable to resective surgery
[13,43]. There are reports of improvement with vagus nerve stim-
ulation (VNS) [44]. There are no published reports on the use of
a ketogenic diet in patients with r(20) syndrome.
The long-term outcome of the syndrome is not well docu-
mented. However, r(20) patients, are at high risk of other compli-
cations of epilepsy including lethal status epilepticus [45]. There
are no reported cases of sudden unexpected death in epilepsy in
r(20) patients, even though it is a possible occurrence in all drug
resistant epilepsies [46].
3. Genetics
3.1. Developmental origins and ring morphology
The diagnosis of ring chromosome 20 syndrome requires iden-
tiﬁcation of the ring chromosome by cytogenetic techniques (as
opposed to array-based studies), as not all rings are associated with
deletions or duplications. In each case, the ring chromosome
replaces one of the normal chromosome 20s and has been found in
patients in both amosaic andnon-mosaic form. Supernumerary ring
chromosome20s (with twonormal 20’s in addition to the ring), have
also been reported. However, these patients present with growth
Fig. 2. Correlation of age of seizure onset and percentage of abnormal cells detected
cytogenetically. Mosaic patients (,) were reported with an abnormal karyotype that
contained some metaphases with two normal chromosome 20s, while non-mosaic (-)
patients were reported with an abnormal karyotype containing no detectable normal
cells.
Fig. 1. (A) Normal waking EEG. (B) Typical ﬁnding of bi-frontal sharp waves in the interictal EEG of a r(20) patient. (C) Ictal EEG recording during non-convulsive status epilepticus
characterized by diffuse low voltage activity following by recruiting rhythm over the frontal areas. After 15e20 s there is appearance of discharges of sharp and slow waves with
anterior predominance. Clinically, the patient showed motor ictal semiology (tonic contraction of both arms followed by a clonic phase with right predominance).
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dysmorphic features, but they do not have seizures [47].
In ring chromosome 20 syndrome, the ring chromosomes have
been reported in multiple tissues and have been seen prenatally in
both amniotic ﬂuid and chorionic villous samples, as well as in
post-natal blood, lymphocytes and skin. The percentage of cells
containing the ring in patients described in the literature ranges
from a few percent up to 100%. Initial attempts to better understand
the link between the ring chromosome and the clinical phenotype
looked for correlations between ring percentage and different
clinical features such as age of onset of seizures, frequency of
seizures and resistance to antiepileptic drugs. From these early
reports, trends began to emerge suggesting that the age of seizure
onset and resistance to drugs inversely correlated with the
percentage of cells containing the ring chromosome [9,30]. Recent
molecular characterizations of two larger cohorts of r(20) patients
with array-based technologies has added further support to these
trends (Fig. 2) while also demonstrating that seizure frequency has
no dependence on ring load in the tissues studied [17,48]. In
addition, these recent studies have begun to unravel details about
the mechanism of ring formation, suggesting that two distinct
classes of ring 20 chromosomes exist with different developmental
origins and ring molecular structure (Fig. 3).
The majority of patients present with a mosaic chromosomal
composition by karyotypewith some percentage of cells having two
normal chromosome 20s and the other cells with one chromosome
20 replaced by a ring (Fig. 3). Note that this deﬁnition of mosaicismshould be contrasted with the phenomenon of “dynamic mosai-
cism” in which secondary abnormalities are a common observation
[1,49]. These secondary abnormalities includemetaphases thatmay
display duplicated rings, broken rings with altered chromosomal
banding as well as loss of the ring chromosome (Fig. 4). While these
abnormalities represent a form of mosaicism, they are found in all
patients with rings, and the additional abnormalities stem from
Fig. 3. (A) Non-mosaic ring sample with no normal cells present. Fluorescence in situ hybridization (FISH) with subtelomere probes (green ¼ 20p, red ¼ 20q) demonstrates that this
non-mosaic ring has subtelomere deletions at one or both arms. (B) Mosaic ring sample with subtelomere repeats intact.
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individual who contains a cell line with two normal chromosome
20s, while a non-mosaic is an individual who lacks a normal cell
line. Individuals without a normal cell line have a more severe
phenotype.
In two independent studies using chromosomal microarray
analysis, individuals who were found to be mosaic by conventional
cytogenetics, had no detectable terminal deletions on the array
[8,17]. The absence of subtelomere repeat deletions via FISH further
suggests that these rings were formed by direct telomereetelomere
fusions [8,9,12,16,17,25,28,31,48]. The lack of deletions in mosaic
patients is also supported by earlier cases inwhich FISHwas carried
out using subtelomere and telomere probes [16]. Two different
developmental mechanisms can explain mosaicism with a cell line
with two normal 20s. The ﬁrst involves post-zygotic fusion of
telomeres in a single cell, with all descendants of that cell inheriting
the aberration, while the second posits the presence of the ring
chromosome from fertilization with subsequent ring opening or
ring loss followed by monosomy rescue. Given data generated
using genotyping markers, both Conlin et al. (2010) and Giardino
et al. (2010) were able to rule out uniparental disomy caused by the
latter, suggesting that de novo rings in mosaic patients form post-
zygotically after fertilization [17,48]. R(20) syndrome appears
spontaneously in most individuals; however, there have been a few
exceptional families reported where a mosaic ring is passed from
one generation to the next [5,8,9]. This has also been shown for
rings of other chromosomes besides chromosome 20, and it has
been hypothesized that there may be an inherited instability of the
chromosome involved leading either to de novo reformation of the
ring or to opening of the ring in the second generation [6,17].
In contrast to those patients with mosaicism for the ring chro-
mosome, a second group of patients presents with an abnormal
karyotype containing a ring chromosome in every cell analyzed.
Developmentally, the uniform presence of cells containing two
normal chromosome 20s implies that the rings formed at the single
cell stage, or earlier during meiosis (i.e. in the egg or sperm prior to
fertilization). The rings in all of these patients were found to havea deletion of either the p or q subtelomere (or both) [17,26,27,29].
Since no consensus breakpoint has been found for patients
analyzed by chromosomal microarray analysis, it suggests that
random chromosomal breakage and fusion and not sequence-
mediated fusion is the underlying mechanism of ring formation.
Non-mosaic patients present with seizures earlier in childhood and
often with more severe phenotypes consistent with the correlation
between ring percentage and age of seizure onset [17,48]. Since
these patients also have deleted genomic content, the more severe
phenotypes, including some minor dysmorphisms, may be associ-
ated with haploinsufﬁciency of genes in the deleted regions.
3.2. Molecular etiology
Despite the strong relationship between the presence of the ring
chromosome and the seizure phenotype, the biological mechanism
by which the ring chromosome causes seizures has remained
elusive. Several hypotheses have been proposed including: (1) the
deletion of candidate genes near the telomeres, (2) epigenetic
silencing of gene expression through a telomere position effect, (3)
uniparental disomy for chromosome 20 and (4) the deleterious
effect of ring instability on cellular function and proliferation. The
presence of two known epilepsy genes, CHRNA4 and KCQN2, within
1.0 Mb of the telomere of the long arm of chromosome 20 at band
20q13.3 led to the early suggestions that the seizures were due to
alterations of these candidate genes; however, current data does
not support this for several reasons. Mutations in KCNQ2 (potas-
sium voltage gated channel, KQT-like subfamily, member 2), have
been associated with benign familial, neonatal seizures (BFNS;
OMIM#: 602235). In this disorder, seizures develop a few hours to
a few days after birth, and the seizures resolve spontaneously,
although affected individuals may be at higher risk for the devel-
opment of secondary epilepsies. The KCNQ2 mutations identiﬁed
include missense, nonsense, and insertions and deletions, consis-
tent with haploinsufﬁciency as the mechanism of disease causation
[50]. Mutations in CHRNA4 (Acetylcholine receptor, neuronal
nicotinic, alpha-4 subunit) have been associated with autosomal
Fig. 4. Dynamic mosaicism is illustrated, with secondary ﬁndings such as monosomy 20, dicentric rings and opened rings.
Fig. 5. Array results from patients with deletions of 20q. Deletions present on ring chromosomes [17] (black) and deletions from patients with terminal deletions [55] (gray) are
both presented. Unique genes in the subtelomeric regions are shown below (RefSeq:hg18). Patient identiﬁers were conserved from the original publications. The CHRNA4 and
KCNQ2 genes are presented in a lighter color, it is notable that not all ring chromosome 20 patients have deletions of these genes, although they all have seizures [17].
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ciated mutations are either missense, or in-frame insertions, which
have been hypothesized to cause disease via a dominant-negative
mechanism [51,52]. Although neither of these phenotypes is
consistent with that seen in ring 20 patients, the severe epileptic
phenotype was hypothesized to result from haploinsufﬁciency of
both genes. However, a report of 2 patients with deletions involving
both KCNQ2 and CHRNA4 has shown that affected individuals had
BFNS, but did not show signs of ADNFLE or the seizure types typical
of r(20) syndrome [50].
Furthermore, mapping of multiple ring 20 chromosomes has
demonstrated that no consensus deletion is shared among r(20)
patients (Fig. 5) [12,17]. In fact, a majority of the patients have
apparently intact ring chromosomes without detectable deletions
by FISH analysis; this suggests that the ring forms as a result of
a direct telomereetelomere fusion [17]. Furthermore, patients with
terminal deletions of either 20p or 20q do not share the phenotype
associated with the ring chromosome 20 [53]. These cases also
weaken the argument for a telomere position effect reducing
expression of genes near the telomeres, since this form of hap-
loinsufﬁciency should manifest in patients with complete loss of
the terminal genes. Nonetheless, it can be argued that the effect of
the ring structure on transcriptional regulation may be different
from terminal chromosome deletions. Molecular analysis has also
ruled out uniparental disomy for chromosome 20 as a cause of the
r(20) associated seizures [17,48].
Future work characterizing expression levels from genes on the
ring chromosome, now possible by RNA sequencing technologies,
will provide the greatest insight into the effect chromosome
structure on gene expression. In addition to interrogating the
expression patterns from genes on the ring chromosome, RNA
sequencing may also shed insight into global expression changes
induced by cells possessing a ring chromosome. RNA sequencing
may also address the hypothesis that there is a deleterious effect of
ring instability on cellular function and proliferation, as we may
learn that gene expression is not altered on the ring chromosome
itself, but rather there may be perturbations of genes associated
with cell growth and division.
4. Conclusion
Ring chromosome 20 syndrome is a rare disorder, but it is
undoubtedly under-diagnosed due to the lack of a distinct clinical
phenotype and absence of systemic malformations or dysmorphic
features. The r(20) chromosome is best diagnosed by chromosome
analysis in peripheral blood, as array-based techniques will not
diagnose ring 20 in the two thirds of cases which are mosaic and do
not have associated deletions or duplications [54]. Therefore, we
recommend that chromosomal studies be carried out in all pediatric
cases of epilepsy of frontal lobe origin, especially those with
intractable seizures, behavioral disorders or cognitive impairment.
While recent studies have begun to shed light on the structure of the
ring chromosomes associatedwith this raredisorder, the underlying
etiology of the clinical features associated with the presence of the
ring chromosome 20 remains uncertain. New technologies associ-
ated with next generation sequencing of both DNA and RNA hold
great promise to elucidate the precise structure of the ring chro-
mosomes, and the changes in gene expression that are associated
with the clinical symptoms of the ring chromosome 20.
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